News

Vaderis News |

Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results

Vaderis News |

Vaderis Receives FDA Fast Track Designation for VAD044 for the Treatment of Hereditary Hemorrhagic Telangiectasia

Vaderis News |

Vaderis Announces Acceptance of Abstract on VAD044 Proof-of-Concept Clinical Trial

Vaderis News |

Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT

Vaderis News |

Vaderis Therapeutics AG announces Clinical Proof-of-Concept Trial in HHT